iShares U.S. Pharmaceuticals ETF (IHE) price, chart and fund profile
Price chart
Fund profile
IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.
- Issuer
- BlackRock Fund Advisors
- Industry
- Healthcare
- Inception
- May 1, 2006
- Expense ratio
- 0.37%
- Net asset value
- $103.96
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.ishares.com↗
Frequently asked questions
What is iShares U.S. Pharmaceuticals ETF (IHE)?
IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.
What is IHE's expense ratio?
iShares U.S. Pharmaceuticals ETF charges an annual expense ratio of 0.37%. The fund is issued by BlackRock Fund Advisors.
How large is IHE?
iShares U.S. Pharmaceuticals ETF manages $1.7B in assets and has traded since May 1, 2006.
How do I buy shares of iShares U.S. Pharmaceuticals ETF (IHE)?
IHE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.